1 / 17

Diabetes and Mental Health

Canadian Diabetes Association 2013 Clinical Practice Guidelines. Diabetes and Mental Health. Chapter 18 David J. Robinson, Meera Luthra , Michael Vallis. DIABETES. MENTAL ILLNESS. Key Points. 2013.

shannon-adkins
Télécharger la présentation

Diabetes and Mental Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Canadian Diabetes Association 2013 Clinical Practice Guidelines Diabetes and Mental Health Chapter 18 David J. Robinson, MeeraLuthra, Michael Vallis

  2. DIABETES MENTAL ILLNESS

  3. Key Points 2013 • Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes • Mental illness increases risk of diabetes and diabetic complications • Patients taking psychiatric medications need metabolic screening • Screening for depression and anxiety is important in patients with diabetes

  4. 1. Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes

  5. 2. Mental illness increases risk of diabetes and diabetic complications • Non-adherence to medication and self-care • Functional impairment • Risk of complications • Healthcare costs • Risk of early mortality Mental Illness Diabetes Depression increases risk of DM by 60%!

  6. Psychoactive Medications May Predispose to Diabetes • Especially second-generation antipsychotics (olanzapine, clozapine, risperidone, quetiapine, aripiprazole, ziprasidone) • Biochemical and lifestyle factors may also contribute • Co-morbid mental illness can worsen diabetes control

  7. 3. Patients taking high-risk psychiatric medications need metabolic screening

  8. Depressive symptoms in 30% of patients with diabetes • Major depressive disorder in 10% • Co-morbid depression worsens clinical outcomes in DM • Lower physical fitness? • Poor medication adherence?

  9. Diabetes Distress • Despondency and emotional turmoil related to diabetes, the need for monitoring and treatment, preoccupation with complications, and loss of relationships • Related to poorer outcomes

  10. 4. Screening for depression and anxiety is important in patients with diabetes Websites with psychological / psychiatric scales: www.phqscreeners.com www.outcometracker.org/scales_library.php.

  11. Treatment • Cognitive-behavioural therapy • Other psychotherapy • Antidepressant medication

  12. Other Psychiatric Associations • Bipolar disorder • Anxiety • Eating disorders • Schizophrenia and other psychotic disorders

  13. Recommendation 1 • Individuals with diabetes should be regularlyscreened for subclinical psychological distress and psychiatric disorders (eg.Depressive and anxiety disorders) by interview[Grade D, Consensus]or with a standardized questionnaire [Grade B, Level 2]

  14. Recommendation 2 2013 • Psychosocial interventions should be integrated into diabetes care plans [Grade B, Level 2], including • Motivational interventions [Grade B, Level 2] • Stress management strategies [Grade B, Level 2] • Coping skills training [Grade A, Level 1A for type 2 diabetes; Grade B, Level 2, for type 1 diabetes] • Family therapy [Grade A, Level 1B] • Case management [Grade B, Level 2]

  15. Recommendation 3 • Antidepressant medication should be used to treat acute depression [Grade A, Level 1A]and for maintenance/prophylactic treatment of depression [Grade A, Level 1A]. Cognitive-behaviour therapy (CBT) alone [Grade B, Level 2]or in combination with antidepressant medication [Grade A, Level 2] may be used to treat people with depression in diabetes.

  16. Recommendation 4 2013 • Antipsychotic medications (especially atypical/second generation) can cause adverse metabolic changes [Grade A, Level 1]. Regular metabolic monitoring is recommended for patients with and without diabetes who are treated with such medications [Grade D, Consensus]

  17. CDA Clinical Practice Guidelines http://guidelines.diabetes.ca – for professionals 1-800-BANTING (226-8464) http://diabetes.ca – for patients

More Related